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plates. Gels without Hap were used as controls. The gels were kept in
culture for 3 weeks in αMEM medium containing 10%FCS. Gel contraction
and cell viability, morphology and metabolism were analyzed.
Results: Gels, attached to surface plates after fabrication, became free-
ﬂoating gels contracted from day 3, only in the presence of cells. A linear
rapid contraction phase was observed until day 7, then a very slow con-
traction phase took place. The incorporation of Hap improved gel stability
as compared to collagen gels without Hap.
Total DNA increased two times from day 3 to day 21, reﬂecting cell
proliferation inside gels. Moreover, while cell metabolism increased all
over the culture period, an important increase was observed after 3 weeks.
Cells cultured in gels showed elongated spindle-shape morphology and a
few dead cells were observed all over the experiment. Microscopy images
showed that cells were randomly distributed on the gel. After proliferation
cells were connected, mainly at the gel surface, which could stabilize
collagen contraction.
Conclusions: This study shows the feasibility and biocompatibility of hy-
droxyapatite supplemented collagen gels for the culture of mesenchymal
stem cells. They could be used as carriers for cell delivery in osteoarticular
regenerative medicine.
532
PRENATAL DEVELOPMENTAL HEALINGWITH INTRA-ARTICULAR
GROWTH HORMONE (IAGH) INJECTIONS TREATS A VARIETY OF
OSTEOARTHRITIC AND RHEUMATOID JOINTS WITH A SUCCESS RATE OF
75% TO 95% AND NO COMPLICATIONS
A.R. Dunn
Mt. Sinai Med. Ctr., Miami Beach, FL
Purpose: To utilize the prenatal developmental scar-free healing promoted
by intra-articular growth hormone (IAGH) injections. The basic science
demonstrates that pre-natal developmental healing (PDH) occurs without
bleeding, clot formation and the in-pouring of inﬂammatory cells and
ﬁbroblasts, the cascade of post-natal healing. PDH produces real articular
cartilage and no ﬁbrocartilage. A study of 66 patients with advanced
osteoarthritis of the knee treated with IAGH resulted in 87 per cent
good and excellent results and the patients did not need total knee
arthroplasty (TKA). In light of these results the author has treated many
other joints with equally good to excellent results. Methodology including
pre-treatment testing and results are here reported.
Methods: Every patient was evaluated before treatment with blood tests,
X-rays and MRI’s. Weight had to be within one standard deviation of
normal.
Patients were instructed in exercising and use of crutches during treatment.
Patients agreed in writing to the requirements for treatment. Many hip,
knee, and ankle patients required arthroscopic debridement and abrasion
chondroplasty prior to receing IAGH injections. Joint were injected with a
range of dosage of recombinant Human Growth Hormone which ranged
from 2.5 mgm to 10 mgm per injection depending on the size of the joint.
Injections were given weekly for 3 to 15 weeks depending on the response
which was determined by bi-weekly X-rays. Patients were allowed to drop
out of the program at will: none dropped out.
Results: The success rate was as follows: Ankles 95%; knees 87%; hips 60%;
subtalar and talonavicular joints 95%; shoulders 75%; elbows 95%; wrists
95%; base of thumb 75%. There were no complications, allergic reactions,
infections, deep vein thrombosis, pulmonary embolism, or deaths from the
IAGH treatments of over 800 patients.
Conclusions: An alternative treatment to total joint arthroplasty and other
treatments is presented. It utilizes the ability of Growth Hormone injections
to provide Pre-natal Developmental Healing. The advantages of PDH are:
ease of application; lack of complications, side-effects and infection; and
high patient satisfaction. The cost of treating hips, knees, and ankles is
1/4 that of joint replacement arthroplasty which can cost US$35,000.00 for
each joint, without complications. If complications occur with joint arthro-
plasties the cost can easily double. Revision arthroplasty also increase the
costs of total joints. Patients treated with IAGH may need booster injections
once every one to ﬁve years and the cost is small.
The author recommends that IAGH treatment be used before indicating
total joints because if the IAGH treatment is not effective in a small
percentage there are no down-sides. No joints have become worse from
IAGH treatment.
In summary, a treatment which is effective, safe, and economical is
presented as alternative to joint replacements.
Therapy – Intraarticular
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Therapeutic EFFECTS OF INTRA-ARTICULAR ADMINISTRATION OF
ULTRA-PURIFIED LOW ENDOTOXIN ALGINATE ON THE PROGRESSION OF
EXPERIMENTAL OSTEOARTHRITIS IN RABBITS
T. Igarashi, N. Iwasaki, D. Kawamura, N. Tsukuda, A. Minami
Hokkaido Univ., Sapporo, Japan
Purpose: Recent clinical studies have demonstrated no therapeutic effects
of HA on preventing the OA progression. We developed highly puriﬁed
biocompatible alginate, which can drastically reduce the endotoxin level.
Our hypothesis was that the ultra-puriﬁed low endotoxin alginate (UPLE-
alginate) could promote anti-arthritic activity in experimental OA. The aims
of this study were to clarify the effect of the UPLE-alginate administration
on OA progression and on joint lubrication, and to determine the adequate
molecular weight of the UPLE-alginate using a rabbit OA model.
Methods: Three UPLE-alginates were prepared: AL20 (MW 0.43×106 Da),
AL100 (1.0×106 Da), and AL500 (1.70×106 Da) (Mochida Pharmaceutical
Co., Ltd., Tokyo, Japan). For comparison, sodium HA (ARTZ® , Kaken Phar-
maceutical Co., Ltd., Tokyo, Japan) were used. OA model and treatment
protocols. Japanese white rabbits (2.8-3.0 kg) were used according to the
established ethical guidelines approved by the local animal care committee.
To induce OA, ACL transection (ACLT) was performed. All knees were
randomly divided into 5 groups as follows; AL20, AL100, AL500, HA, and
normal saline (NS) groups. Intra-articular injections of a 0.3 ml of each
material (1%) started at 4 weeks for a total of 5 weekly injections. All
animals were euthanized at 9 weeks.
Assessments. Gross morphologic ﬁndings were assessed according to criteria
by Yoshioka et al (n=10 knees). For histological evaluation, the sections
were stained with safranin-O. Cartilage degeneration was quantitatively
analyzed using the scoring system described by Kikuchi (n=8 knees). Six
knees in each group were prepared for mechanical testing. The effect of the
intraarticular injection on joint lubrication was assessed using a pendulum
friction tester designed by our laboratory for small samples. The friction
coeﬃcient was calculated from the obtained data.
Statistical analysis. Signiﬁcant differences among the groups were assessed
by a two-way ANOVA followed by multiple-comparison post hoc tests.
Two-tailed P values less than 0.05 were considered statistically signiﬁcant.
Results: Gross Morphology. The NS and HA groups showed extensive carti-
lage erosion mainly at the medial femoral condyle. The alginate injection
groups exhibited milder degradation than the HA and NS groups. The
AL100 group showed lower severity grades. Severe OA changes of grade
3 (overt ﬁbrillation) and grade 4 (erosion) at the medial femoral condyle
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